Global Biotech Ingredient Market – Industry Trends and Forecast to 2029

Global Biotech Ingredient Market, By Type (Innovative Biotech APIs, Generic biotech APIs/ Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), Expression System (Mammalian, Microbial, Yeast, Plant, Insect) – Industry Trends and Forecast to 2029.

Biotech Ingredient Market Analysis and Size

A considerable shift in consumer preferences towards, advanced, safe and potent cosmetics solutions represents one of the major factor which is encouraging the adoption of biotech ingredients to manufacture new cosmetic formulas, ranging from collagen to hyaluronic acid. Moreover, the rising demand for sustainable and organic products is promoting the use of biotech ingredients in hybrid skincare products. The leading major market players are also investing in research and development (R&D) to introduce innovative products in the market. 

Data Bridge Market Research analyses that the biotech ingredient market was valued at USD 54.02 billion in 2021 and is expected to reach USD 81.65 billion by 2029, registering a CAGR of 5.30 % during the forecast period of 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Biotech Ingredient Market Scope and Segmentation

Market Definition

Biotech ingredients are complex and large chemical mixtures which has found in animals, microbial and botanical biological sources and are structurally identical with those compounds which has found in natural organisms. Biotech ingredients are natural ingredients which consist of oleoresins, essential oils, and other plant extracts.  These ingredients are generally derived using four major techniques: solvent extraction, steam distillation, carbon dioxide extraction or cold pressing or compression.

Global Biotech Ingredient Market Dynamics

Drivers

• Rising demand for natural and organic products

The major factor which is expected to drive the growth of the global biotech ingredients market is increasing consumer shift towards organic and natural products. This can be recognised due to the increasing awareness regarding side effects of synthetic ingredients. 

• Rising demand of generic medicines

The growing use of generic medicines especially herbal immunity boosters in the wake of pandemic are expected to drive the market's growth rate during the forecast period. This is owed to the concept that they are used amply as both raw material and finished for many patent and generics medicines and other products. 

Furthermore, growing usage of personal care products, scented and herbs products is a major factor which is escalating the market growth rate. The increasing occurrence of chronic ailments such as cancer,  increasing importance of generics, rising geriatric population, are some of the major factors which is expected to drive the growth of the biotech ingredient market during the forecast period of 2022-2029. 

Opportunities

• Surging new developments

Researchers have developed a technique by using biotech ingredients with the help of cell biology in the cosmetic industry. This will increase the demand for biotech ingredients in cosmetics industry. Major market players have already started using biotech ingredients in their product in the cosmetics industry, which are expected to create immense market growth opportunities.

• surging innovated methods

the surging innovated methods by market players further offer numerous growth opportunities within the market. For instance, Novozymes, which is a biotech company has developed a unique method for hyaluronic acid by using microbial fermentation. It is mainly used in the formulation of several skin care products such as lotions and facial creams.

Moreover, increasing acceptance of biopharmaceuticals will also create several opportunities and lead to the growth of the biotech ingredient market during the above mentioned period.  

Restraints/ Challenges

• Limited accessibility of raw material

The limited availability of raw material because of fluctuating weather conditions during the crop season may hinder the growth of the biotech ingredient market during the forecast period.

Furthermore, strict environment rules to stop exploitation of land can also hinder the biotech ingredient market growth in above mentioned period.

This biotech ingredient market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biotech ingredient market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

COVID-19 Impact on Biotech Ingredient Market

The biotech ingredient sector was combined effect by COVID-19 pandemic but the lockdowns during pandemic posed a number of problems for industry participants which is including logistical difficulties in shipping end goods, disrupted supply chains, and recruiting staff from quarantines. The coronavirus outbreak the government has imposed lockdowns that have temporarily disturbed the activities of several industries such as biotech ingredient industry.

On the brighter side, the use of generic medicines especially herbal immunity boosters has increased, due to this growth of biotech ingredient industry is in a downward spiral. Thus, COVID-19 left a combined impact on the growth of the biotech ingredient market.

 Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Global Biotech Ingredient Market Scope

The biotech ingredient market is segmented on the basis of type, product and expression system. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Innovative Biotech APIs
• Generic biotech APIs/ Biosimilars

 Product

• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

 Expression System

• Mammalian
• Microbial
• Yeast
• Plant
• Insect

Biotech Ingredient Market Regional Analysis/Insights

The biotech ingredient market is analysed and market size insights and trends are provided by country, type, product and expression system as referenced above.

The countries covered in the biotech ingredient market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Europe dominates the biotech ingredient market in terms of market share due to rising demand of biotech ingredients in fragrances and cosmetics in this region.

North America is anticipated to be the fastest developing region during the forecast period of 2022-2029 due to increasing R&D activities to develop innovative bio-based product, growing adoption of biotech ingredients, along with the presence of potential industry market players in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Biotech Ingredient Market Share Analysis

The biotech ingredient market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biotech ingredient market.

Some of the major players operating in the biotech ingredient market are:

• AbbVie Inc. (U.S.)
• Boehringer Ingelheim International GmbH. (Germany)
• Bristol-Myers Squibb Company (U.S.)
• Lilly (U.S.), GSK Plc (U.K.)
• Merck & Co (U.S.).
• Pfizer Inc. (U.S.)
• Sanofi (France)
• Teva Pharmaceutical Industries Ltd. (Israel)
• AstraZeneca (U.K.)
• Mylan N.V  (U.S.)
• Novartis AG (Switzerland)
• BD (U.S.)
• bioMérieux (France)
• Cepheid Inc. (U.S.)
• Bruker (U.S.)